Document is current

Article History

Received: 16 October 2019

Accepted: 18 February 2020

First Online: 27 February 2020

Ethics approval and consent to participate

: All steps of the study were performed in accordance with the Declaration of Helsinki (ethical principles for medical research involving human subjects) and the ethics committee of the Shahid Sadoughi University of Medical Sciences. The study was approved by the ethics committee of the University (IR. IAU. YAZD. REC. 1394.008) and registered at the Iranian Registry of Clinical Trials (IRCT20190603043801N1). Participants were given a clear explanation of the purpose and background of the study, the fact that their participation in and withdrawal from the study would be voluntary, and the confidential management of their data. All participants gave their written informed consent. The cost of medication was funded by the resources of the research project; no expenses were borne by the patients. The patients were informed in detail about the study and gave their informed consent. They were free to discontinue their participation in any stage of the study, for any reason, or for no reason at all. All patient data were treated confidentially, were inaccessible to any person or organization, and were only reported collectively.

: Not applicable

: All authors declare that they have no financial or non-financial competing interests.